SavedAdd your journal

Journals / Cukurova Medical Journal / 2021 / Cilt: 46 - Sayı: 1

Relationship between inflammatory markers and infection in chronic kidney disease

Kronik böbrek hastalığında inflamasyon belirteçleri ile enfeksiyon ilişkisi

Sultan SİPAHİ
Seher KIR
Melda DİLEK
Pages
177–185
Publication Date
2021-03-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A total of 72 patients with CKD (Glomerular filtration rate

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study was to evaluate the importance of C-reactive protein (CRP) and procalcitonin (PCT) in the diagnosis and monitoring of infections in chronic kidney disease (CKD) patients.
📊
Key Findings & Data:Materials and Methods: In this study, 1538 hospitalized patients in the nephrology division of Ondokuz Mayıs University between March 2012 and June 2014 were evaluated.
💡
Conclusion & Impact:A total of 72 patients with CKD (Glomerular filtration rate
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Chronic kidney disease · C-reactive protein · procalcitonin

Abstract

Purpose: The aim of this study was to evaluate the importance of C-reactive protein (CRP) and procalcitonin (PCT) in the diagnosis and monitoring of infections in chronic kidney disease (CKD) patients. Materials and Methods: In this study, 1538 hospitalized patients in the nephrology division of Ondokuz Mayıs University between March 2012 and June 2014 were evaluated. A total of 72 patients with CKD (Glomerular filtration rate

Özet

Amaç: Bu çalışmada kronik böbrek hastalığı (KBH) olan hastalarda gelişen enfeksiyonların tanı ve takibinde C-reaktif protein (CRP) ve prokalsitonin (PCT)’in önemini değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Bu çalışmada, Mart 2012 - Haziran 2014 tarihleri arasında Ondokuz Mayıs Üniversitesi nefroloji bölümünde yatarak tedavi gören 1538 hasta değerlendirildi. Çalışmaya herhangi bir bakteriyel enfeksiyon nedeniyle tedavi almış ve tüm verileri eksiksiz olan 72 KBH (Glomerüler filtrasyon hızı

🔖

Cite This Article

SİPAHİ, S., KIR, S., DİLEK, M. (2021). Relationship between inflammatory markers and infection in chronic kidney disease. Cukurova Medical Journal, Cilt: 46 - Sayı: 1, 177–185. https://ajindex.com/articles/115463

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol. 2019;23:437–47
  2. Filiopoulos V, Vlassopoulos D. Inflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomes. Inflamm Allergy Drug Targets. 2009;8:369–82 3. Rojas L, Muñoz P, Kestler M, Arroyo D, Guembe M, Rodríguez-Créixems M et al. Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality. J Hosp Infect. 2013;85:196– 205
  3. Hildebrand A. Komenda P, Miller L, Rigatto C, Verrelli M, Sood AR et al. Peritonitis and exit site infections in first nations patients on peritoneal dialysis. Clin J Am Soc Nephrol. 2010;5:1988–95
  4. Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Norpoth M et al. C reactive protein in patients with chronic renal diseases. Ren Fail. 2001;23:551–62
  5. Kalantar-Zadeh K. Inflammatory marker mania in chronic kidney disease: pentraxins at the crossroad of universal soldiers of inflammation. Clin J Am Soc Nephrol. 2007;2:872–5
  6. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206–17
  7. Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med. 2007;50:34–41
  8. Guz G, Colak B, Hizel K, Reis KA, Erten Y, Bali M et al. Procalcitonin and conventional markers of inflammation in peritoneal dialysis patients and peritonitis. Perit Dial Int. 2006;26:240–8
  9. Tang H, Huang T, Jing J, Shen H, Cui W. Effect of procalcitoninguided treatment in patients with infections: a systematic review and meta-analysis. Infection. 2009;37:497–507
  10. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605–8
  11. Pepys MB, Hirschfield GM. C-rective protein: a critical update. J Clin Invest. 2003;111:1805–12
  12. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M et al. Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect. 2011;17:1–59
  13. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG et al. International clinical practice guidelines for the treatment of acute uncomplicatedmcystitis and pyelonephritis in women: a 2010 update by the Infectiou